908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Ticker SymbolMASS
Company name908 Devices Inc
IPO dateDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Number of employees246
Security typeOrdinary Share
Fiscal year-endDec 18
Address645 Summer Street
CityBOSTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code02210
Phone19787294478
Websitehttps://908devices.com/
Ticker SymbolMASS
IPO dateDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data